Dong, S
USING PRECISEINHALE FOR CONTROLLED VOLUNTEER EXPOSURES WITH AEROSOLS EXTRACTED FROM CLINICAL INHALERS Per Gerde1 ,2, CarlOlof Sjberg1 Helen Bckroos1 & Helena Litorp3,4 1Inhalation Sciences AB, Hlsovgen 7, Novum, 141 57 Huddinge, Sweden 2IMM, Karolinska Institutet, Nobels vg 13, 171 77 Stockholm, Sweden 3CTC Clinical Trial Consultants, Dag Hammarskjlds vg 10B, 752 37 Uppsala, Sweden 4Department of Global Public Health, Karolinska Institutet, 171 77 Stockholm, Sweden Summary: The PreciseInhale (PI) platform was used to extract clinical inhaler doses from the pressurized metered dose inhaler (pMDI) Evohaler Seretide forte, Fluticasone Propionate (FP) 250 g, Salmeterol Xinafoate (SMX) 25 g and then expose human volunteers by visually prompting controlled administration from the clinical exposure module of PI
This balanced approach produces faster resolution of pain without compromising the healing process
This targeted delivery system allows for effective dosing at just 100mg daily while providing more efficient results than traditional glutathione supplements
Treating obesity and/or diabetes, therefore, can reduce the effects of PCOS
The optimal time to take Semaglutide GLP-1 for weight loss can vary based on individual factors